Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adicon HoldingsADCNF 75 EV-to-EBIT is 38.47 as of Jul. 25, 2026, which is 18% above its 10-year median of 32.51. GuruFocus rates ADCNF with a GF Score™ of 75/100 and a GF Value™ of $1.40. The stock has 6 warning signs investors should review. Among 104 Medical Diagnostics & Research companies, Adicon Holdings ranks worse than 80.77% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Adicon Holdings's Enterprise Value for the quarter that ended in Dec. 2025 was $694.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adicon Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $14.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adicon Holdings EV-to-EBIT Related Terms
Adicon Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Adicon Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Adicon Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adicon Holdings EV-to-EBIT vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Adicon Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Adicon Holdings's EV-to-EBIT falls into.
Adicon Holdings's current Enterprise Value is $540.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adicon Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $14.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adicon Holdings (ADCNF) has a EV-to-EBIT of 38.47 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Adicon Holdings and its competitors. This is 18% above median its historical median of 32.51. Over the past decade, Adicon Holdings' EV-to-EBIT has ranged from 7.16 to 50.17. According to the industry distribution chart, Adicon Holdings ranks #84 out of 104 companies in the Medical Diagnostics & Research industry, placing it in the top 80.8%.
Is Adicon Holdings' EV-to-EBIT too high?
Adicon Holdings' current EV-to-EBIT of 38.47 is 18% above median its 10-year median of 32.51. Over the past 10 years, this metric has ranged from a low of 7.16 to a high of 50.17. The Medical Diagnostics & Research industry median EV-to-EBIT is 22.57. Adicon Holdings' value of 38.47 is 70.5% above this industry median. Based on the distribution chart, Adicon Holdings ranks #84 out of 104 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Adicon Holdings has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Adicon Holdings' EV-to-EBIT compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Adicon Holdings ranks #84 out of 104 companies for EV-to-EBIT. This places Adicon Holdings in the lower half of its industry. The industry median EV-to-EBIT is 22.57. Adicon Holdings' value of 38.47 is 70.5% above this benchmark. Historically, Adicon Holdings' own EV-to-EBIT has ranged from 7.16 to 50.17 over the past decade. While the company's 10-year median is 32.51 vs. the industry median of 22.57, Adicon Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Diagnostics & Research company?
The median EV-to-EBIT among Medical Diagnostics & Research companies is 22.57, based on 104 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adicon Holdings's current EV-to-EBIT of 38.47 is 70.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Adicon Holdings and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-EBIT is 22.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adicon Holdings's current EV-to-EBIT is 38.47, which is 18% above median its own 10-year median of 32.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adicon Holdings stock overvalued right now?
Adicon Holdings (ADCNF) has a current EV-to-EBIT of 38.47. The stock's GF Value™ is $1.40, compared to a current price of $0.65 — trading 53.6% below its estimated fair value. The current EV-to-EBIT is 38.47, which is 18% above median its 10-year median of 32.51 and 70.5% above the Medical Diagnostics & Research industry median of 22.57. Adicon Holdings' overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Adicon Holdings (ADCNF), the current EV-to-EBIT is 38.47 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adicon Holdings (ADCNF) Overvalued in 2026?
Based on GuruFocus' analysis, Adicon Holdings stock appears to be undervalued.
The current stock price of $0.65 is trading 53.6% below its estimated GF Value™ of $1.40.
Key valuation signals for ADCNF:
EV-to-EBIT: 38.47 (18% above median its 10-year median of 32.51)
GF Value™: $1.40 vs. price of $0.65 (53.6% below fair value)
Industry Position: 70.5% above the Medical Diagnostics & Research median (#84 of 104)
No single metric tells the full story. See the ADCNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adicon Holdings Ltd is a ICL service provider in China. It offers comprehensive testing services to hospitals and health check centers through an integrated network of self-operated laboratories across China. Its testing services platform includes clinical laboratories, pathology laboratories, reproductive genetics laboratories, gene laboratories, and mass spectrometry laboratories, consisting of over 4,000 medical diagnostic tests, the introduction of over 300 new high-end diagnostic tests.
75GF Score
Get the complete analysis for ADCNF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADCNF has been successfully added to your 
